Articles |
From the Department of Clinical Biology, Division of Biochemistry, University of Bergen, Haukeland University Hospital, N-5021 Bergen, Norway (Z.A.M., R.J.U., R.K.B) and the Department of Chemistry, University of Bergen, N-5007 Bergen, Norway (K.D., J.S.).
Correspondence to Ziad A. Muna, Department of Clinical Biology, Division of Biochemistry, University of Bergen, Haukeland University Hospital, N-5021 Bergen, Norway. E-mail ziad.muna{at}ikb.uib.no
| Abstract |
|---|
|
|
|---|
Key Words: tetradecylthioacetic acid 3-thia fatty acids oxidized LDL atherosclerosis lipid peroxidation copper reduction.
| Introduction |
|---|
|
|
|---|
Recently, the effect of sulfur substituted fatty acid analogues on lipid metabolism and blood lipids has been extensively studied.7 Long-chain thia fatty acids are activated to their CoA thioesters in the endoplasmic reticulum (ER).8 They cannot be ß-oxidized but are metabolized by extra mitochondrial ß-oxidation and sulfur oxidation in the ER followed by peroxisomal ß-oxidation to short sulfinyl dicarboxylic acids.9 In vivo, long-chain 3-thia fatty acids are incorporated into phospholipids,10 particularly in heart and hepatocytes. Among plasma lipoproteins, they were found within VLDL and LDL.11 TTA has been reported as one of the most potent lipid lowering of the monocarboxylic 3-thia fatty acids, causing reduction in both cholesterol (data to be published) and triacylglycerol in rats.12 TTA induces proliferation of peroxisomes and mitochondria7,1315 that may lead to increased oxidative stress in the body. For instance, when rats were treated with peroxisome proliferators (ciprofibrate and perfluorodecanoic acid) there was an increase in 8-hydroxy-deoxyguanosine (8-OH-dG), which is a marker of oxidative damage of DNA.1618 In order to reveal redox properties of TTA, we tested the compound in two quite different experimental models: the effect of TTA on oxidative modification of LDL caused by copper and nonmetal oxidants, and its effect on the ascorbate induced oxidation of the DNA-fragment 2-deoxyguanosine. In both systems TTA behaved as an antioxidant.
| Methods |
|---|
|
|
|---|
Fatty Acid Analogues
The different 3-thia fatty acids were synthesized as previously
described.19 These were dissolved in ethanol or in
potassium hydroxide and added in the indicated concentrations
simultaneously with the oxidative agent, or as
indicated.
| Synthesis of 1-[14C]-Tetradecylthioacetic Acid |
|---|
|
|
|---|
| LDL Preparation and Storage Time |
|---|
|
|
|---|
After being dialyzed it was necessary to test the stability of the LDL under storage conditions. Four different LDL preparations obtained from 4 different healthy donors were subjected to copper ion oxidation after different storage intervals (0 to 6 days, 0 to 4°C and 7 days, -80°C). The lag time, the half-time for the maximum diene production (T1/2), the rate of propagation, and the maximum diene production were monitored. The results showed that the LDL stored at 0 to 4°C gave values that were within the experimental error of those obtained with freshly prepared LDL, while the oxidation parameters of LDL stored at -80°C were outside experimental error (data not shown). Therefore, we used LDL stored at 4°C and within 6 days after it was dialyzed.
| Copper IonInduced LDL Oxidation and Monitoring of Conjugated Dienes |
|---|
|
|
|---|
| Preincubation |
|---|
|
|
|---|
| Electrophoretic Mobility |
|---|
|
|
|---|
| Measurement of Lipid Peroxides |
|---|
|
|
|---|
| Comparing Methods for Detecting Oxidation of LDL |
|---|
|
|
|---|
| Analysis of 8-OH-dG |
|---|
|
|
|---|
| Scavenging of DPPH Radical |
|---|
|
|
|---|
| Wavelength Spectra Measurement |
|---|
|
|
|---|
| The Effect of TTA on the Oxidation State of Copper |
|---|
|
|
|---|
| Interactions Between LDL and TTA |
|---|
|
|
|---|
| Results |
|---|
|
|
|---|
-Tocopherol and reduced glutathione increased the lag
time while addition of the polyunsaturated fatty acid,
eicosapentaenoic acid (20:5 n-3) reduced the
lag time (data not shown). No changes in the lag time of LDL oxidation
were obtained by the addition of the sulfinyl or sulfonyl forms of TTA,
tetradecyloxyacetic acid, and 3, 14-dithiahexadecanedioic acid (Table 1
|
|
|
Lipid Peroxidation
TTA reduced the production of lipid peroxides originating
from LDL oxidation, being almost blocked when 80 µmol/L
of TTA was added and incubated for 1 or 2 hours (Fig 3
). However, the antioxidant capacity of
TTA was less effective in inhibiting lipid peroxide production
after 3 hours.
|
Electrophoretic Mobility
The changed electrophoretic mobility of LDL oxidized for
various time intervals is shown in Fig 4
.
Addition of TTA reduced the REM of oxidized LDL in a dose-dependent
manner. Indeed, the REM of the copper ion-treated LDL incubated for 1
and 2 hours in the presence of 80 µmol/L of TTA was
similar to native LDL.
|
To test the effect of TTA and palmitic acid on the electrophoresis method, increasing concentrations of TTA and palmitic acid (dissolved in KOH) were added to LDL (50 µg/ml) which had been oxidized for six hours by 4 mmol/L AAPH at 37°C. Addition of TTA at a concentration of more than 160 µmol/L, was found to increase the electrophoretic mobility, probably explained by an increase in the net negative charge caused by the sulfur atom. Palmitic acid up to 320 µmol/L, had no effect on the electrophoretic mobility (data not shown).
The Effect of TTA on Ascorbic Acid-Induced 2-Deoxyguanosine
Modification
Fig 5
shows the effects of TTA on
ascorbic acid-induced formation of 8-OH-dG from 2-deoxyguanosine
incubated for different time intervals. This 3-thia fatty acid reduced
in a dose-dependent manner the 8-OH-dG formation at all time intervals.
More than 50% reduction in ascorbic acid-induced formation of 8-OH-dG
was observed in the presence of 100 µmol/L TTA. No
inhibition of 8-OH-dG generation was observed when the sulfonyl form of
TTA or tetradecyloxyacetic acid was present (Table 2
).
|
|
Mechanisms of Action
Binding of Copper Ion to TTA
In order to verify the mechanisms by which TTA inhibits oxidation
of the LDL, its effect on copper ion binding was tested. This was done
by measuring the UV and the visible absorbance spectra of TTA in the
presence and absence of copper ion. The results were compared with
those obtained by adding palmitic acid that was used as a control. The
visible absorbance spectra measure the d-d transition for copper from
nondegenerated t2g-orbitals (which make the band very broad)
to dx2-y2-orbitals where the
separation increased with the stability of the complex, ie, the more
stable the complex is, the smaller the
max.31 This means that copper in
H2O (
max 821 nm) are less stable than in
palmitic acid (
max 814 nm), which again are less stable
than in TTA (
max 794 nm) (Fig 6A
).
|
The UV spectra (Fig 6B
) of the TTA-copper complex showed two main bands
at 275 nm and 332 nm indicating that there are two different
transitions in the TTA-copper complex. In comparison, the palmitic
acid-copper complex had only a single band, at 275 nm. The common
absorbance peak at 275 nm, is due to charge-transfer transition from
oxygen nonbonding electrons to the antibonding (t2g*)
orbitals of the copper ion. The band at 332 nm in the TTA-copper
complex is assumed to be due to the charge-transfer transition of the
sulfur nonbonding electrons to the antibonding (t2g*) of the
copper ion.32 This suggests that in the palmitic
acid-copper complex there is an oxygen-copper bond, while in the
TTA-copper complex there are both sulfur-copper and oxygen-copper
bonds. The shift of
max to longer wavelengths results
from weakening the copper-ligand bond.31 Apparently, the
copper-oxygen bond is stronger than the copper-sulfur one.
The Effect of TTA on the Oxidation State of Copper
Table 3
shows that neither palmitic
acid nor TTA has any effect on the oxidation state of copper, ie,
copper (II) was not reduced to copper (I).
|
LDL Oxidation Initiated by Azo Compounds
To examine possible alternative mechanisms, LDL was subjected to
copper ion-independent oxidation, initiated by the lipid and water
soluble azo compounds AMVN and AAPH, respectively. The effect of TTA
and palmitic acid on the AAPH and AMVN induced LDL oxidation as
assessed by electrophoresis is shown in Table 4
. With increased amounts of TTA, the REM
of the LDL particle decreased. It should be emphasized that this method
underscores the real effect due to the interference of TTA with the
method (see above). Nevertheless, TTA decreased the REM as compared to
palmitic acid. When AMVN was used, TTA inhibited LDL oxidation in a
dose-dependent manner. 160 µmol/L TTA reduced the content
of lipid peroxides by 84% and the REM by 28%. In comparison with AAPH
as the oxidative agent, the lipid peroxides were reduced by 35% and
the REM by 9% (Table 4
).
|
DPPH Radical Scavenging
We also tested the capacity of TTA to scavenge the DPPH free
radical and compared the effect with that of probucol, a synthetic
antioxidant, and
-tocopherol, a natural antioxidant. As
shown in Fig 7
, TTA failed to scavenge
the DPPH radicals.
|
Interactions Between LDL and TTA
Radioactive 14C labeled TTA was incorporated into the
LDL particle under the in vitro conditions (Fig 8
). Preincubation of TTA with the LDL
particle had almost the same preventive effect on the oxidizability of
the LDL particle (Table 5
) as when TTA
was added simultaneously with copper ions (Table 1
).
|
|
| Discussion |
|---|
|
|
|---|
TTA not only reduced the peroxidation of lipids in LDL, but
obviously also protected the protein moiety of the LDL particle against
oxidation as is evident from its beneficial effect on the
electrophoretic mobility (Table 4
).
Under the present experimental conditions TTA was incorporated into
the LDL particle (Fig 8
), and obviously very fast as deduced from the
finding that the protection of LDL oxidation was almost the same
whether TTA was preincubated with LDL before oxidation, or added
simultaneously with the pro-oxidant. Our finding is
supported by others who found TTA in the LDL fraction of the TTA
treated hamsters.11
Earlier, it has been reported that 2 hours after a single dose (150
mg/kg body weight) of TTA to rats, plasma concentration was
about 100 µmol/L.33 Thus, the TTA
concentrations used in this study were kept well within a range which
may be of biological relevance (Fig 2
). This may also be true for using
copper as a pro-oxidant, since its in vivo involvement in
atherosclerosis is becoming more evident through
several lines of studies.3436
An intriguing question concerns the mechanism by means of which TTA
behaves as an antioxidant. TTA did not change the oxidation state of
copper ions (Table 3
), implying that it was kept in the copper (II)
state. Therefore, the antioxidant effect of TTA might be due to
attenuating the redox cycle between the copper (II) and copper (I)
redox states. This cycle has been proposed as the mechanism of action
by which copper confer its catalytic role, and that copper (I) rapidly
forms the ultimate initiating radical, that is capable of abstracting a
hydrogen atom from a polyunsaturated fatty acid.22,37
Binding of copper on the other hand could not be the full explanation
for several reasons. First, TTA was effective also when metal
independent oxidants like azo compounds (Table 4
), and ascorbate were
used (Table 2
). Second, the fact that copper induced LDL oxidation was
delayed, and not prevented by TTA, contradicts that the effect of TTA
could be explained only by the formation of an inactive TTA-copper
complex. The introduction of an extended lag period into the oxidation
process by TTA (Fig 1
) is typical for an antioxidant that acts by
radical scavenging. In contrast, metal ion-binding antioxidants are
expected to give a constant inhibition through the
reaction.39 Moreover, the results from the experiments with
the azo compounds, AMVN and AAPH, suggest that TTA was able to scavenge
the peroxyl radicals, with higher capacity to scavenge the peroxyl
radicals generated in the lipid phase than in the water phase (Table 4
). This is consistent with our finding that TTA is
incorporated into the LDL particle and most probably is located in the
lipid phase. It seems plausible that TTA mainly incorporated in the
lipid phase as radiolabeled TTA injected intravenously into
rats was found in the triacylglycerol fraction of
the LDL (data to be published).
Nevertheless, the change of the spectra of copper caused by TTA and
palmitic acid, is consistent with the formation of a
copper-fatty acid complex (Figs 6A
& 6B). In agreement with this
assumption is the finding of Balasubramanian et al38 that
nonesterified fatty acids such as palmitic acid, myristic acid and
lauric acid inhibit iron-dependent lipid peroxidation.
The negative result obtained with TTA in the classical DPPH radical
scavenging test (Fig 7
), indicates that the conditions required by TTA
to take part in redox reactions are different from that of
-tocopherol and probucol. On the other hand, the
substantial power of TTA to attenuate the effect of radicals generated
by ascorbate and protect DNA-fragments from oxidation, is of
considerable biological interest (Fig 5
). If a prediction of the free
radical reactions is to be made, one should consider the essential
physico-chemical factors like the one electron reduction potential
which is a key thermodynamic property,40 and the rate
constant for the reaction which is another important factor. Thus, it
must be kept in mind that a reaction that is in principle
thermodynamically possible may not be kinetically feasible, ie, the
rate constant for the reaction is too small to be biologically
significant.41 Given that the key elements involved in LDL
oxidation are not totally identified and that considerable variation in
the physico-chemical factors results from different incubation
conditions when different compounds are questioned, it is not
surprising to find that TTA behaves differently in different radical
generating systems.
Although the data of the present study cannot be translated directly into the in vivo situation, one may point out that when rats were treated with TTA for 12 weeks, there was a significant increase in the plasma monounsaturated fatty acids. This was mainly accounted for by an increased level of oleic acid (18:1 n-9) and a decrease in the polyunsaturated fatty acids accompanied with reduced levels of linoleic acid (18:2 n-6).42 It has been reported that the LDL content of 18:2 n-6 strongly correlates with either the rate of oxidation or the extent of oxidation, the percent of 18:1 n-9 in LDL correlate well with the delay before LDL oxidation and the reduction in the content of polyunsaturated fatty acids in LDL particles will decrease the substrate being available to be oxidized.43 The in vivo effects of TTA that have been reported in the above mentioned study affecting the lipid metabolism and thus, LDL lipid composition and structure indicate further antioxidant properties.
In summary, this study suggests that 3-thia fatty acids exert antioxidant properties with TTA being the most potent among them. It appears that charge and fatty acid chain length play an important role in altering the oxidative resistance that might be mediated through the lipid solubility. We have for the first time described intrinsic antioxidant properties of TTA that may be of biopharmacological interest both in the prevention of atherosclerosis and in the protection of DNA against oxidative damage. The underlying redox mechanism seems to be a combination of metal ion binding and radical scavenging. Further studies are in progress to clarify molecular mechanisms and biological relevance.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received December 12, 1996; accepted July 31, 1997.
| References |
|---|
|
|
|---|
2. Maxwell SR. Can anti-oxidants prevent ischaemic heart disease? J Clin Pharm Ther. 1993;18:8595.[Medline] [Order article via Infotrieve]
3. Esterbauer H, Dieber Rotheneder M, Waeg G, Striegl G, Jurgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol. 1990;3:7792.[Medline] [Order article via Infotrieve]
4.
Carew TE, Schwenke DC, Steinberg D. Antiatherogenic
effect of probucol unrelated to its hypocholesterolemic
effect: evidence that antioxidants in vivo can selectively inhibit low
density lipoprotein degradation in macrophage-rich fatty
streaks and slow the progression of atherosclerosis in
the Watanabe heritable hyperlipidemic rabbit.
Proc Natl Acad Sci U S A.. 1987;84:77257729.
5.
Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima
A, Yoshida H, Kawai C. Probucol prevents the progression of
atherosclerosis in Watanabe heritable
hyperlipidemic rabbit, an animal model for familial
hypercholesterolemia. Proc Natl Acad Sci
U S A. 1987;84:59285931.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915924.[Medline] [Order article via Infotrieve]
7. Berge RK, Kryvi H, Aarsaether N, Aarsland A, Lillehaug JR, Skorve J. Proliferation of peroxisomes and mitochondria and modulation of lipid metabolizing enzymes by hypolipidaemic non-ß-oxidizable fatty acids (3-thia fatty acids), 1993.
8. Aarsland A, Berge RK. Peroxisome proliferating sulphur- and oxy-substituted fatty acid analogues are activated to acyl coenzyme A thioesters. Biochem Pharmacol. 1991;41:5361.[Medline] [Order article via Infotrieve]
9. Berge RK, Hvattum E. Impact of cytochrome P450 system on lipoprotein metabolism. Effect of abnormal fatty acids (3-thia fatty acids). Pharmacol Ther. 1994;61:345383.[Medline] [Order article via Infotrieve]
10. Grav HJ, Asiedu DK, Berge RK. Gas chromatographic measurement of 3- and 4-thia fatty acids incorporated into various classes of rat liver lipids during feeding experiments. J Chromatogr B Biomed Appl. 1994;658:110.[Medline] [Order article via Infotrieve]
11. Frøyland L, Asiedu DK, Vaagenes H, Garras A, Lie Ø, Totland GK, Berge RK. Tetradecylthioacetic acid incorporated into very low density lipoprotein: Changes in the fatty acid composition and reduced plasma lipids in cholesterol-fed hamsters. J Lipid Res. 1995;36:25292540.[Abstract]
12. Frøyland L, Madsen L, Sjuresen W, Garras A, Lie Ø, Jon S, Rustan AC, Berge RK. Effect of 3-thia Fatty Acids on The Lipid Composition of Rat Liver, Lipoproteins, and Heart. J Lipid Res. In press.
13. Berge RK, Aarsland A, Kryvi H, Bremer J, Aarsaether N. Alkylthioacetic acid (3-thia fatty acids)a new group of non-beta-oxidizable, peroxisome-inducing fatty acid analogues. I. A study on the structural requirements for proliferation of peroxisomes and mitochondria in rat liver. Biochim Biophys Acta. 1989;1004:345356.[Medline] [Order article via Infotrieve]
14. Aarsland A, Aarsaether N, Bremer J, Berge RK. Alkylthioacetic acids (3-thia fatty acids) as non-beta-oxidizable fatty acid analogues: a new group of hypolipidemic drugs. III. Dissociation of cholesterol- and triglyceride-lowering effects and the induction of peroxisomal beta-oxidation. J Lipid Res. 1989;30:17111718.[Abstract]
15. Skorve J, Asiedu D, Rustan AC, Drevon CA, al Shurbaji A, Berge RK. Regulation of fatty acid oxidation and triglyceride and phospholipid metabolism by hypolipidemic sulfur-substituted fatty acid analogues. J Lipid Res. 1990;31:16271635.[Abstract]
16. Huang CY, Wilson MW, Lay LT, Chow CK, Robertson LW, Glauert HP. Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Cancer Lett. 1994;87:223228.[Medline] [Order article via Infotrieve]
17. Floyd RA. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 1990;4:25872597.[Abstract]
18.
Kasai H, Crain PF, Kuchino Y, Nishimura S, Ootsuyama A,
Tanooka H. Formation of 8-hydroxyguanine moiety in cellular DNA by
agents producing oxygen radicals and evidence for its repair.
Carcinogenesis. 1986;7:18491851.
19. Spydevold Ø, Bremer J. Induction of peroxisomal beta-oxidation in 7800 C1 Morris hepatoma cells in steady state by fatty acids and fatty acid analogues. Biochim Biophys Acta. 1989;1003:7279.[Medline] [Order article via Infotrieve]
20.
Carlson K. Lipoprotein fractionation. J Clin
Pathol. 1973;26:3237.
21.
Lopes Virella MF, Stone P, Ellis S, Colwell JA.
Cholesterol determination in high-density lipoproteins
separated by three different methods. Clin Chem. 1977;23:882884.
22. Gieseg SP, Esterbauer H. Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett. 1994;343:188194.[Medline] [Order article via Infotrieve]
23. Kleinveld HA, Hak Lemmers HL, Stalenhoef AF, Demacker PN. Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem. 1992;38:20662072.[Abstract]
24. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989;6:6775.[Medline] [Order article via Infotrieve]
25.
Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects
human low density lipoprotein more efficiently against lipid
peroxidation than does alpha-tocopherol. Proc Natl
Acad Sci U S A. 1991;88:16461650.
26. Frei B, Gaziano JM. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res. 1993;34:21352145.[Abstract]
27.
Kasai H, Nishimura S. Hydroxylation of deoxyguanosine
at the C-8 position by ascorbic acid and other reducing agents.
Nucleic Acids Res. 1984;12:21372145.
28. Blois MS. Antioxidant Determinations by the Use of a Stable Free Radical. Nature. 1958;181:11991200.
29. Angelici J. Synthesis and Technique in Inorganic Chemistry. Philadelphia: W. B. Saunders Company, 1977.
30.
Cederbaum AI, Wainio WW. Binding of Iron and Copper to
Bovine Heart Mitochondria. I. Quantitative Aspects and Stability.
J Biol Chem. 1972;247:45934603.
31. Douglas B, McDaniel D, Alexander J. Concepts and Models of Inorganic Chemistry. Canada: John Wiley & Sons, Inc, 1994.
32. Kojima M, Fujita J. Preparation, racemization, and deuteration of 2-(methylthio) propionato-S, O and 2-sulfinatopropionato-S, O complexes of cobalt(III). Bull Chem Soc Jpn. 1983;56:29582964.
33. Asiedu DK, Demoz A, Skorve J, Grav HJ, Berge RK. Acute modulation of rat hepatic lipid metabolism by sulphur-substituted fatty acid analogues. Biochem Pharmacol. 1995;49:10131022.[Medline] [Order article via Infotrieve]
34. Mowri H, Ohkuma S, Takano T. Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions. Biochim Biophys Acta. 1988;963:208214.[Medline] [Order article via Infotrieve]
35. Salonen JT, Salonen R, Seppanen K, Kantola M, Suntioinen S, Korpela H. Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. BMJ. 1991;302:756760.
36. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J. 1992;286:901905.
37. Patel RP, Svistunenko D, Wilson MT, Darley-Usmar VM. Reduction of Cu(II) by lipid hydroperoxides: implications for the copper-dependent oxidation of low-density lipoprotein. Biochem J. 1997;322:425433.
38. Balasubramanian KA, Nalini S, Cheeseman KH, Slater TF. Nonesterified fatty acids inhibit iron-dependent lipid peroxidation. Biochim Biophys Acta. 1989;1003:232237.[Medline] [Order article via Infotrieve]
39. Halliwell B, Aeschbach R, Loliger J, Aruoma OI. The characterization of antioxidants. Food Chem Toxicol. 1995;33:601617.[Medline] [Order article via Infotrieve]
40. Wardman P. Reduction potentials of one-electron couples involving free radicals in aqueous solution. J Phys Chem Ref Data. 1989;18:16371755.
41. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys. 1993;300:535543.[Medline] [Order article via Infotrieve]
42. Asiedu DK, Frøyland L, Vaagenes H, Lie Ø, Demoz A, Berge RK. Long-term effect of tetradecylthioacetic acid: a study on plasma lipid profile and fatty acid composition and oxidation in different rat organs. Biochim Biophys Acta. 1996;1300:8696.[Medline] [Order article via Infotrieve]
43. Reaven P. The role of dietary fat in LDL oxidation and atherosclerosis. Nutr Metab Cardiovasc Dis. 1996;6:5764.
This article has been cited by other articles:
![]() |
E. Dyroy, T. H. Rost, R. J. Pettersen, B. Halvorsen, O. A. Gudbrandsen, T. Ueland, Z. Muna, F. Muller, J. E. Nordrehaug, P. Aukrust, et al. Tetradecylselenoacetic Acid, a PPAR Ligand With Antioxidant, Antiinflammatory, and Hypolipidemic Properties Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 628 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dyroy, A. Yndestad, T. Ueland, B. Halvorsen, J. K. Damas, P. Aukrust, and R. K. Berge Antiinflammatory Effects of Tetradecylthioacetic Acid Involve Both Peroxisome Proliferator-Activated Receptor {alpha}-Dependent and -Independent Pathways Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1364 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Berge, K. J. Tronstad, P. Bohov, L. Madsen, and R. K. Berge Impact of mitochondrial {beta}-oxidation in fatty acid-mediated inhibition of glioma cell proliferation J. Lipid Res., January 1, 2003; 44(1): 118 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Pettersen, Z. A. Muna, K. K.J. Kuiper, E. Svendsen, F. Muller, P. Aukrust, R. K. Berge, and J. Erik Nordrehaug Sustained retention of tetradecylthioacetic acid after local delivery reduces angioplasty-induced coronary stenosis in the minipig Cardiovasc Res, November 1, 2001; 52(2): 306 - 313. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |